Case report: Oxaprozin and fatal toxic epidermal necrolysis

Journal of Burn Care and Rehabilitation

Volumn 19, Issue 4, 1998, Pages 321-323

  Paul, Chester N ^a   Voigt, David W ^a   Clyne, Kurt E ^a   Hansen, Sean L ^a  

^a Saint Elizabeth Regional Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; CAPTOPRIL; FAMOTIDINE; FUROSEMIDE; IMIPENEM; METHYLPREDNISOLONE; MORPHINE; NABUMETONE; OXAPROZIN; SULFADIAZINE SILVER; SULTAMICILLIN;

AGED; ANALGESIA; ANTIBIOTIC THERAPY; ARTICLE; BLISTER; CASE REPORT; DEBRIDEMENT; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LOW BACK PAIN; ORAL DRUG ADMINISTRATION; OSTEOARTHRITIS; TOXIC EPIDERMAL NECROLYSIS; WOUND CARE;

EID: 0031928189     PISSN: 02738481     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004630-199807000-00009     Document Type: Article

References (16)

1. Roujeau J, Kelly J, Naldi L, Rzany B, Stern RS, Anderson T, et al. Medication use and the risk of Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis. N Engl J Med 1995;333:1600-7.
2. Chan HL, Stern RS, Arndt KA, Langlois J, Jick SS, Jick H, et al. The incidence of Erythema multiforme, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis. Arch Dermatol 1990;126:43-7.
3. Marvin JA, Heimbach DM, Engrav LH, Harnar TJ. Improved treatment of the Stevens-Johnson Syndrome. Arch Surg 1984;119:601-5.
4. Taylor JA, Grube B, Heimbach DM, Bergman AB. Toxic epidermal necrolysis, a comprehensive approach. Clin Ped 1989;28:404-7.
5. Herndon DN, ed. Total Burn Care. Philadelphia: WB Saunders; 1996. p. 432.
6. Correia O, Chosidow O, Saiag P, Bastuji-Garin S, Revuz J, Roujeau JC. Evolving pattern of drug-induced toxic epidermal necrolysis. Dermatology 1993;186:32-7.
7. Parsons JM. Toxic epidermal necrolysis. Int J Dermatol 1992;31:749-68.
8. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994; 331:1272-85.
9. Lyell A. Toxic epidermal necrolysis (the scalded skin syndrome): a reappraisal. Brit J Dermatol 1979;100:69-86.
10. Heimbach DM, Engrav LH, Marvin JA, Harnar T J, Grube BJ. Toxic epidermal necrolysis. JAMA 1987;257:2171-5.
11. Guillaume JC, Roujeau JC, Revuz J, Penso D, Tour R. The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell's Syndrome). Arch Dermatol 1987;123:1166-70.
12. Heng MC, Allen SG. Efficacy of cyclophosphamide in toxic epidermal necrolysis. J Am Acad Dermatol 1991;25:778-86.
13. Roujeau JC, Huynh, TN, Bracq C, Guillaume JC, Revuz J, Touraine R. Genetic susceptibility to toxic epidermal necrolysis. Arch Dermatol 1987;123:1171-3.
14. Kramer MS, Leventhal JM, Hutchinson, TA, Feinstein AR. An algorithm for the operational assessment of adverse drug reactions. JAMA 1979;242:623-32.
15. Physician's desk reference, 50th ed., 1996. Relafen product information 2510-2.
16. Physician's desk reference, 50th ed., 1996. Daypro product information 2426-8.